Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Findlay

Showing results (121-130 of 170) with videos related to

Pageof 17
Sort By:
Journal of Virology|October 26, 2012
Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infectionZhiqiang Qin, Lu Dai, Michael Defee, et al.
Molecular Pharmacology|April 23, 2004
Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrugVictoria J Findlay, Danyelle M Townsend, Joseph E Saavedra, et al.
Carcinogenesis|January 11, 2012
ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotypeA M Smith, V J Findlay, S G Bandurraga, et al.
Bioorganic & Medicinal Chemistry|March 21, 2006
Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analoguesT Mavromoustakos, P Moutevelis-Minakakis, C G Kokotos, et al.
Clinical Endocrinology|April 1, 1988
Inhibin: definition and nomenclature, including related substancesH G Burger, M Igarashi, D T Baird, et al.
The Prostate|March 30, 2011
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progressionDavid P Turner, Victoria J Findlay, Omar Moussa, et al.
Journal of the American Chemical Society|October 22, 2010
Reductions of challenging organic substrates by a nickel complex of a noninnocent crown carbene ligandNeil J Findlay, Stuart R Park, Franziska Schoenebeck, et al.
Molecular Carcinogenesis|September 3, 2013
Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancerVictoria J Findlay, R Eric Moretz, Cindy Wang, et al.
Molecular Cancer Therapeutics|September 25, 2014
SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repressionVictoria J Findlay, Cindy Wang, Lourdes M Nogueira, et al.
Cancer Medicine|February 9, 2021
Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparitiesThomas Curran, Zequn Sun, Brielle Gerry, et al.
Pageof 17

Showing results (121-130 of 170) with videos related to

Sort By:
Pageof 17
Journal of Virology|October 26, 2012
Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infectionZhiqiang Qin, Lu Dai, Michael Defee, et al.
Molecular Pharmacology|April 23, 2004
Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrugVictoria J Findlay, Danyelle M Townsend, Joseph E Saavedra, et al.
Carcinogenesis|January 11, 2012
ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotypeA M Smith, V J Findlay, S G Bandurraga, et al.
Bioorganic & Medicinal Chemistry|March 21, 2006
Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analoguesT Mavromoustakos, P Moutevelis-Minakakis, C G Kokotos, et al.
Clinical Endocrinology|April 1, 1988
Inhibin: definition and nomenclature, including related substancesH G Burger, M Igarashi, D T Baird, et al.
The Prostate|March 30, 2011
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progressionDavid P Turner, Victoria J Findlay, Omar Moussa, et al.
Journal of the American Chemical Society|October 22, 2010
Reductions of challenging organic substrates by a nickel complex of a noninnocent crown carbene ligandNeil J Findlay, Stuart R Park, Franziska Schoenebeck, et al.
Molecular Carcinogenesis|September 3, 2013
Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancerVictoria J Findlay, R Eric Moretz, Cindy Wang, et al.
Molecular Cancer Therapeutics|September 25, 2014
SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repressionVictoria J Findlay, Cindy Wang, Lourdes M Nogueira, et al.
Cancer Medicine|February 9, 2021
Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparitiesThomas Curran, Zequn Sun, Brielle Gerry, et al.
Pageof 17